Showing results (361-370 of 1,794) with videos related to

Sort By:
Pageof 180
Mabs|April 18, 2024
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibodyEva Schlein, Ken G Andersson, Tiffany Dallas, et al.
Mabs|April 23, 2024
Targeted CQA analytical control strategy for commercial antibody products: Replacing ion-exchange chromatography methods for charge heterogeneity with multi-attribute monitoringAdam R Evans, Joseph Mulholland, Michael J Lewis, et al.
Mabs|April 9, 2024
Enrichment strategy and initial characterization of heterodimers enriched from a co-formulated cocktail of therapeutic antibodies against SARS-COV-2Sophia Liu, Yuetian Yan, Cody M Secor, et al.
Mabs|January 18, 2026
Rapid and selective characterization of antibody-drug conjugates in complex sample matrices by native affinity liquid chromatography-mass spectrometryDan Bach Kristensen, Nanna Sofie Eskesen, Clara Coll-Satue, et al.
Mabs|February 6, 2026
Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safetyGihoon You, Jungwoo Choi, Chorong Yang, et al.
Mabs|February 5, 2026
Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseasesWenbo Jiang, Lingyun Li, Weili Xue, et al.
Mabs|December 8, 2025
Engineering multispecific antibodies with complete killing selectivity through the closed-loop integration of machine learning and high-throughput experimentationJustin Grace, Pierre-Yves Colin, Dan Foxler, et al.
Mabs|November 18, 2025
IgG binding characteristics of ferret Fcγ receptorsXiaoxuan Ge, Matthew Stoner, Joshua A Weiner, et al.
Mabs|January 17, 2025
With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development processSilvia Crescioli, Shashi Jatiani, Lenny Moise
Mabs|December 9, 2024
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancerPeter Jung, Stefan P Glaser, Jing Han, et al.
Pageof 180